Abilify is classified as an atypical antipsychotic [1]. It is also known as a dopamine-serotonin system stabilizer [2].
What conditions does Abilify treat?
Abilify is prescribed to treat schizophrenia, bipolar I disorder (manic or mixed episodes), and major depressive disorder [1]. It is also used in children aged 6 years and older for Tourette's disorder and irritability associated with autistic disorder [1].
How does Abilify work?
Abilify works by altering the activity of certain chemicals in the brain, specifically dopamine and serotonin [1]. These neurotransmitters play a role in mood, behavior, and thought processes [3]. By balancing these chemicals, Abilify helps to alleviate symptoms associated with the conditions it treats [1][3].
What are the different types of antipsychotic medications?
Antipsychotic medications are broadly divided into two main classes: first-generation (typical) and second-generation (atypical) antipsychotics [4]. Atypical antipsychotics, like Abilify, generally have a lower risk of certain side effects, such as extrapyramidal symptoms, compared to typical antipsychotics [4].
When does Abilify's patent expire?
Information regarding specific patent expiry dates for Abilify can be found on resources like DrugPatentWatch.com [5]. DrugPatentWatch.com tracks patent information, exclusivity periods, and potential market entry dates for generic and biosimilar drugs [5].
What are the potential side effects of Abilify?
Common side effects of Abilify include nausea, vomiting, constipation, headache, dizziness, drowsiness, and blurred vision [1]. More serious side effects can occur, such as tardive dyskinesia (involuntary movements), neuroleptic malignant syndrome, and metabolic changes like increased blood sugar and cholesterol [1]. Patients taking Abilify should discuss any concerns about side effects with their healthcare provider [1].